Variant report

Variant	rs2925141
Chromosome Location	chr17:18015113-18015114
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:8)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:18008903..18011616-chr17:18013439..18016712,4	K562	blood:
2	chr17:18012129..18016581-chr17:18018314..18021860,5	K562	blood:
3	chr17:18013158..18015444-chr17:18018445..18021397,3	MCF-7	breast:
4	chr17:18008952..18011744-chr17:18014672..18019225,4	MCF-7	breast:
5	chr17:18014082..18015832-chr17:18026108..18028285,2	MCF-7	breast:
6	chr17:18008903..18011333-chr17:18013439..18016712,3	K562	blood:
7	chr17:18003932..18005616-chr17:18013733..18015364,2	K562	blood:
8	chr17:17991589..17993318-chr17:18013576..18015292,2	MCF-7	breast:

No data

Extended variants
information (count: 36 )
Associated
traits (count: 3 )

rSNPs within LD-proxies of this variant (count:24)

rs_ID	r²[population]
rs2272570	0.83[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs2925139	1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs2925140	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs2925142	0.98[AMR][1000 genomes];0.97[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs2925143	0.95[AMR][1000 genomes];0.97[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs2955361	0.95[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs2955362	0.98[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs2955363	0.83[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs2955364	0.98[AMR][1000 genomes];0.97[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs2955374	0.81[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs2955375	0.95[AMR][1000 genomes];0.97[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs2955386	0.83[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs2955387	1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs2975000	0.91[AMR][1000 genomes];0.92[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs2975001	0.95[AMR][1000 genomes];0.97[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs2975002	0.80[AMR][1000 genomes];0.93[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs2975003	0.91[EUR][1000 genomes]
rs2975004	0.91[EUR][1000 genomes]
rs2975005	0.89[EUR][1000 genomes]
rs4513153	0.95[AMR][1000 genomes];0.97[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs4925139	0.83[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs6502635	1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs7225972	0.95[AMR][1000 genomes];0.84[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs8077176	0.95[AMR][1000 genomes];0.97[EUR][1000 genomes];0.95[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:12 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv531183	chr17:17571035-18205309	Genic enhancers Weak transcription Enhancers Strong transcription Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	123 gene(s)	inside rSNPs	diseases
2	nsv916653	chr17:17651916-18454952	Enhancers Strong transcription Active TSS Genic enhancers Flanking Active TSS Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	144 gene(s)	inside rSNPs	diseases
3	nsv533142	chr17:17691726-18236686	Active TSS Flanking Active TSS Enhancers Strong transcription Weak transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	116 gene(s)	inside rSNPs	diseases
4	nsv960429	chr17:17951047-18027679	Strong transcription Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer Enhancers Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	14 gene(s)	inside rSNPs	diseases
5	nsv482491	chr17:17959577-18153920	Enhancers Genic enhancers Flanking Active TSS Active TSS Weak transcription Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	38 gene(s)	inside rSNPs	diseases
6	nsv1061162	chr17:17978838-18259234	Flanking Active TSS Weak transcription Genic enhancers Active TSS Enhancers Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	47 gene(s)	inside rSNPs	diseases
7	nsv492305	chr17:17980441-18424702	Flanking Active TSS Enhancers Strong transcription Transcr. at gene 5' and 3' Weak transcription Active TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	68 gene(s)	inside rSNPs	diseases
8	nsv907769	chr17:18000321-18064195	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	17 gene(s)	inside rSNPs	diseases
9	nsv457697	chr17:18003845-18046290	Strong transcription Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	13 gene(s)	inside rSNPs	diseases
10	nsv574527	chr17:18003845-18046290	Weak transcription Enhancers Strong transcription Bivalent Enhancer Active TSS Genic enhancers ZNF genes & repeats Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	13 gene(s)	inside rSNPs	diseases
11	nsv907770	chr17:18003845-18098018	Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	29 gene(s)	inside rSNPs	diseases
12	nsv907771	chr17:18013560-18098018	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	26 gene(s)	inside rSNPs	diseases

mRNA abundance (count:3)

SNP	Gene	Cis/trans	Tissue	Source
rs2925141	ATPAF2	cis	Thyroid	GTEx
rs2925141	ATPAF2	cis	Heart Left Ventricle	GTEx
rs2925141	DRG2	cis	Artery Aorta	GTEx

Chromatin state (count:39 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:18002400-18019600	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
2	chr17:18003200-18021000	Weak transcription	Psoas Muscle	Psoas
3	chr17:18003800-18015200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
4	chr17:18004800-18015400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
5	chr17:18005400-18017000	Weak transcription	HepG2	liver
6	chr17:18010600-18015400	Weak transcription	HUES64 Cell Line	embryonic stem cell
7	chr17:18010600-18015800	Weak transcription	H9 Cell Line	embryonic stem cell
8	chr17:18010600-18030400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
9	chr17:18010800-18015400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
10	chr17:18010800-18020800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
11	chr17:18011000-18015200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
12	chr17:18011000-18017200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
13	chr17:18011000-18018000	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
14	chr17:18011000-18022600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
15	chr17:18011200-18018000	Weak transcription	Right Ventricle	heart
16	chr17:18011200-18019400	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
17	chr17:18011200-18022000	Weak transcription	Placenta	Placenta
18	chr17:18011200-18026200	Weak transcription	Placenta Amnion	Placenta Amnion
19	chr17:18011400-18015200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
20	chr17:18011800-18018200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
21	chr17:18012200-18016400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
22	chr17:18012400-18015200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
23	chr17:18013000-18015200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
24	chr17:18014000-18015200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
25	chr17:18014200-18018400	Enhancers	Liver	Liver
26	chr17:18014600-18022400	Weak transcription	Spleen	Spleen
27	chr17:18014800-18015400	Enhancers	Fetal Muscle Trunk	muscle
28	chr17:18014800-18015400	Enhancers	Fetal Muscle Leg	muscle
29	chr17:18014800-18015600	Enhancers	H1 Cell Line	embryonic stem cell
30	chr17:18014800-18015600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
31	chr17:18014800-18015600	Enhancers	HSMMtube	muscle
32	chr17:18014800-18015800	Enhancers	Skeletal Muscle Male	skeletal muscle
33	chr17:18015000-18015200	Enhancers	HMEC	breast
34	chr17:18015000-18015400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
35	chr17:18015000-18015600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
36	chr17:18015000-18015600	Enhancers	HUES6 Cell Line	embryonic stem cell
37	chr17:18015000-18015800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
38	chr17:18015000-18015800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
39	chr17:18015000-18015800	Enhancers	Skeletal Muscle Female	skeletal muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links